Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The cost of providing and receiving treatment for opioid dependence can determine its adoption. To compare the cost of clinic-based methadone (MC, n=23), office-based methadone (MO, n=21), and office-based buprenorphine (BO, n=34) we performed an analysis of treatment and patient costs over 6 months of maintenance in patients who had previously been stabilized for at least one year. We performed statistical comparisons using ANOVA and chi-square tests and performed a sensitivity analysis varying cost estimates and intensity of clinical contact. The cost of providing one month of treatment per patient was $147 (MC), $220 (MO) and $336 (BO) (p<0.001). Mean monthly medication cost was $93 (MC), $86 (MO) and $257 (BO) (p<0.001). The cost to patients was $92 (MC), $63 (MO) and $38 (BO) (p=0.102). Sensitivity analyses, varying cost estimates and clinical contact, result in total monthly costs of $117 to $183 (MC), $149 to $279 (MO), $292 to $499(BO). Monthly patient costs were $84 to $133 (MC), $55 to $105 (MO) and $34 to $65 (BO). We conclude that providing clinic-based methadone is least expensive. The price of buprenorphine accounts for a major portion of the difference in costs. For patients, office-based treatment may be less expensive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567 · cited 1×
“Buprenorphine and methadone maintenance have similar efficacy, although some findings demonstrate greater retention and less illicit drug use with methadone (Amato et al., 2005).”
BackgroundCounseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351 · cited 3×
“These data were collected between 2002 and 2005 (Fiellin et al., 2006).”
MethodResultSelf-citationSullivan, L. E., Chawarski, M., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.12.008 · Cited by 110
Self-citationAvants, S. K., Margolin, A., Sindelar, J. L., Rounsaville, B. J., Schottenfeld, R., Stine, S., Cooney, N. L., Rosenheck, R. A., Li, S.-H., & Kosten, T. R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.27 · Cited by 108
Self-citationDATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program (DATCAP)
Roebuck, M. C., French, M. T., & McLellan, A. T. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00067-9 · Cited by 72
Financing and cost of standard and enhanced methadone treatment
Bradley, C. J., French, M. T., & Rachal, J. V. (1994) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(94)90096-5 · Cited by 52
Cited by
Schackman, B. R., Leff, J. A., Polsky, D., Moore, B. A., & Fiellin, D. A. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1962-8 · Cited by 100
“Patient costs, including visit time, travel time, and monthly transportation costs, were derived from the previous cost study.(31) Time costs were calculated by multiplying the duration of the visit and travel by the state minimum wage of $8.”
MethodSelf-citationPatterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program
Gordon, A. J., Lo-Ciganic, W.-H., Cochran, G., Gellad, W. F., Cathers, T., Kelley, D., & Donohue, J. M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000164 · Cited by 76
“…using buprenorphine (eitherbuprenorphine monotherapy or buprenorphine/naloxone pharmacotherapy) is an evidence-based, cost effective treatment for opioid use disorder (OUD) (Fudala et al., 2003; Fiellin et al., 2006; Barnett, 2009; Jones et al., 2009; Mattick et al., 2014; Volkow et al., 2014).”
BackgroundMethodMorgan, J. R., Quinn, E. K., Chaisson, C. E., Ciemins, E., Stempniewicz, N., White, L. F., Linas, B. P., Walley, A. Y., & LaRochelle, M. R. (2022) · Medical Care · doi:10.1097/mlr.0000000000001689 · Cited by 30
Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis
King, J. B., Sainski-Nguyen, A. M., & Bellows, B. K. (2016) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2015.1135847 · Cited by 20
Metadata
- Authors
- Jones, E. S., Moore, B. A., Sindelar, J. L., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 99
- Issue
- 1-3
- Pages
- 132-140
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2128589571
- Cited by
- 66
- References
- 7
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2008.07.013
- The paper
- Jones, E. S., Moore, B. A., Sindelar, J. L., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2009). Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2008.07.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.